Valuation

CGENCompugen

StockNasdaqİsrailHealth careEU retail: available

8/10

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
Metric	CGEN	Sector median	vs median
P/E	5,4	15,6 · n=8	%66 below
P/B	1,8	2,3 · n=14	%20 below
P/S	2,6	3,5 · n=11	%26 below
EV/EBIT	2,8	16,9 · n=7	%83 below
Free-cash-flow yield	%16,6	%5,0 · n=12	%234 above
Dividend yield	%0,00	%1,67 · n=58	%100 below
Return on equity	%44,8	%2,5 · n=14	%1.713 above
Return on invested capital	%128,1	%4,6 · n=11	%2.675 above
Gross margin	%87,3	%66,3 · n=8	%32 above
Net debt / EBITDA	−3,14	—	—

Value factor: 93 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

Instrument	P/E	P/B	EV/EBIT	Free-cash-flow yield	Dividend yield	Smart Score
NVSNovartis AG	20,0	6,1	16,9	%6,3	%3,2	10/10
SNYSanofi	11,1	1,2	15,3	%8,3	%6,1	7/10
ALCAlcon	31,8	1,4	25,2	%5,6	%0,6	5/10
BNTXBioNTech SE	—	1,0	—	%1,4	%0,0	—/10
STESTERIS	26,3	2,9	19,8	%4,4	%0,9	7/10
ICLRICON plc	307,9	1,4	56,6	%6,8	%0,0	3/10
CRSPCRISPR Therapeutics AG	—	2,8	—	−%7,6	%0,0	1/10
ABCLAbCellera Biologics	—	4,2	—	−%3,2	%0,0	1/10
ZLABZai Lab Ltd	—	4,2	—	−%5,5	%0,0	1/10
AUPHAurinia Pharmaceuticals	7,0	3,6	—	—	%0,0	—/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 31 Ara 2025 · filed 02 Mar 2026

Buradan sözleşmeden çıkın · AB tüketicileri: Bir satın alma işlemini iptal etmek için 14 gün.